As of 2025-11-15, the Relative Valuation of Antibe Therapeutics Inc (ATE.TO) is (5.82) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.30 CAD, the upside of Antibe Therapeutics Inc based on Relative Valuation is -2071.3%.
The range of the Relative Valuation is (4.65) - (9.28) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.1x - 26.5x | 16.4x |
| Forward P/E multiples | 13.1x - 26.2x | 16.4x |
| Fair Price | (4.65) - (9.28) | (5.82) |
| Upside | -1677.1% - -3244.5% | -2071.3% |
| Date | P/E |